Randomised Controlled TrialtaVNS

Meniere Disease treated with transcutaneous auricular vagus nerve stimulation combined with betahistine Mesylate: A randomized controlled trial

Wu D, Liu B, Wu Y, Wang Y, Sun J, Yang J, Duan J, Liu G, Cao K, Zhang Y, et al.

Brain Stimulation · 2023

Key finding

After 12 weeks, the THI (-11.00, 95%CI, -14.87 to -7.13; P < 0.001), DHI (-47.26, 95%CI, -50.23 to -44.29; P < 0.001), VAS of aural fullness (-2.22, 95%CI, -2.95 to -1.49; P<0.01), and Pure Tone Thresholds (-7.07, 95%CI, -9.07 to -5.06; P<0.001) were significantly differed between the two groups.

Condition
Tinnitus
Stimulation
taVNS
Evidence tier
Randomised Controlled Trial
Participants
View on DOI

Cite this study

Wu, D., Liu, B., Wu, Y., Wang, Y., Sun, J., Yang, J., Duan, J., Liu, G., Cao, K., Zhang, Y., & Rong, P. (2023). Meniere Disease treated with transcutaneous auricular vagus nerve stimulation combined with betahistine Mesylate: A randomized controlled trial. Brain Stimulation, 16(6), 1576-1584. https://doi.org/10.1016/j.brs.2023.10.003

Related studies in Tinnitus

Summary by Vagus Research. Always consult the primary source for the authoritative record.

Stay Current with the Research

Join researchers and practitioners exploring the science of vagus nerve stimulation. Receive curated research summaries and evidence updates.

No spam. Unsubscribe at any time. We respect your privacy.